Literature DB >> 10987183

Synovial giant cells in rheumatoid arthritis: expression of cystatin C, but not of cathepsin B.

T Hansen1, P K Petrow, A Gaumann, G Keyszer, R Bräuer, J Kriegsmann.   

Abstract

This study was designed to investigate the expression of the matrix degrading proteinase cathepsin B and its endogenous inhibitor cystatin C in rheumatoid arthritis (RA) with special regard to multinucleated synovial giant cells (SGC). We applied an immunohistochemical double-labeling technique. SGC strongly expressed cystatin C and CD68, but were negative for cathepsin B. This staining pattern occurred in osteoclasts as well. Our findings support the idea that in RA matrix destruction by cathepsin B is not mediated by SGC or osteoclasts, but by mononuclear synoviocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987183     DOI: 10.1016/S0940-2993(00)80055-X

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  4 in total

Review 1.  Role of IL-10 in the progression of kidney disease.

Authors:  Inna Sinuani; Ilia Beberashvili; Zhan Averbukh; Judith Sandbank
Journal:  World J Transplant       Date:  2013-12-24

2.  Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis.

Authors:  J P Morko; M Söderström; A-M K Säämänen; H J Salminen; E I Vuorio
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

3.  Serum levels of cystatin C in patients with malignancy.

Authors:  Keiko Nakai; Masayuki Kikuchi; Keiko Fujimoto; Yoshito Kaneko; So Omori; Kenji Nakai; Akira Suwabe
Journal:  Clin Exp Nephrol       Date:  2008-03-05       Impact factor: 2.801

4.  Effect of prolonged standardized bed rest on cystatin C and other markers of cardiovascular risk.

Authors:  Karin Arinell; Kjeld Christensen; Stéphane Blanc; Anders Larsson; Ole Fröbert
Journal:  BMC Physiol       Date:  2011-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.